Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View:Bullish
| Metric | BIIB | TMO |
|---|
| Close | 249.59 | 669.54 |
| Market Cap | $36.5B | $255B |
| 1M | +3.57% | −3.53% |
| P/E (TTM) | 104.9 | 36.6 |
| Forward P/E | 16.5 | 25.5 |
| P/E 5-Yr Percentile | 99 | 80 |
| P/S | 3.5 | 5.5 |
| P/B | 1.9 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $2.8B | $12.1B |
| Revenue YoY | +10.6% | +9.1% |
| Gross Margin | 73.3% | — |
| Latest Quarter EPS | -0.14 | 4.64 |
| Avg Post-Earnings Move | ±1.8% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 1.85% |
| 90-Day Net Insider Buying | — | −$20.2M |
BIIB · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)